Central Nervous System-Specific Outcomes of Phase 3 Randomized Clinical Trials in Patients With Advanced Breast Cancer, Lung Cancer, and Melanoma.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 34014298.
- Also identified by DOI 10.1001/jamaoncol.2021.1359 and PMC identifier 8138748.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study determines the proportion of phase 3 clinical trials for patients with metastatic breast cancer, lung cancer, and melanoma that included patients with brain metastases and/or evaluated central nervous system–specific end points.
Medical subject headings
- Breast Neoplasms
- Lung Neoplasms
- Melanoma